Shanghai Aladdin Biochemical Technology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005XD0
CNY
22.85
0.65 (2.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
170.73
251.69
166.39
143.18
130.18
155.95
139.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
170.73
251.69
166.39
143.18
130.18
155.95
139.14
Raw Material Cost
55.13
96.98
67.46
64.30
56.20
63.45
61.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.30
5.26
3.54
12.81
1.34
0.57
0.99
Selling and Distribution Expenses
49.57
50.74
33.68
31.99
30.24
34.24
25.88
Other Expenses
1.43
2.00
1.32
0.12
1.46
1.48
1.31
Total Expenditure (Excl Depreciation)
124.30
172.96
117.91
110.31
102.40
113.00
101.57
Operating Profit (PBDIT) excl Other Income
46.4
78.7
48.5
32.9
27.799999999999997
42.9
37.599999999999994
Other Income
2.73
1.97
2.12
0.93
1.31
1.34
0.36
Operating Profit (PBDIT)
48.09
79.83
58.07
34.59
45.04
42.97
44.39
Interest
5.30
5.26
3.54
12.81
1.34
0.57
0.99
Exceptional Items
-0.01
-0.70
0.09
-0.02
-0.21
0.14
0.10
Gross Profit (PBDT)
115.60
154.71
98.93
78.89
73.98
92.50
77.59
Depreciation
0.00
11.67
11.67
9.46
9.46
8.64
8.64
Profit Before Tax
42.79
62.20
42.96
12.29
34.03
33.90
34.86
Tax
5.50
6.87
4.47
3.22
4.43
2.48
3.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
29.09
44.30
29.30
4.28
24.18
26.19
25.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
29.09
44.30
29.30
4.28
24.18
26.19
25.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
8.19
13.60
9.19
4.80
5.42
5.16
5.94
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
37.29
57.90
38.49
9.08
29.60
31.35
31.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
987.25
969.31
1,066.48
1,036.02
1,071.04
1,066.07
1,039.22
Earnings per share (EPS)
0.09
0.13
0.09
0.01
0.07
0.07
0.08
Diluted Earnings per share
0.09
0.13
0.09
0.01
0.07
0.07
0.08
Operating Profit Margin (Excl OI)
26.57%
26.3%
26.61%
16.9%
26.32%
21.15%
25.43%
Gross Profit Margin
25.06%
29.35%
32.83%
15.19%
33.41%
27.28%
31.27%
PAT Margin
17.04%
17.6%
17.61%
2.99%
18.58%
16.8%
18.18%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 31.11% vs 32.18% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 26.01% vs 73.10% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 3.89% vs 37.85% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 307.69% vs 225.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Shanghai Aladdin Biochemical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
170.73
0
170.73
Other Operating Income
0.00
0.00
0.00
Total Operating income
170.73
0
170.73
Raw Material Cost
55.13
0
55.13
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.30
0
5.30
Selling and Distribution Expenses
49.57
0
49.57
Other Expenses
1.43
0.00
1.43
Total Expenditure (Excl Depreciation)
124.30
0
124.30
Operating Profit (PBDIT) excl Other Income
46.43
0.00
46.43
Other Income
2.73
0
2.73
Operating Profit (PBDIT)
48.09
0
48.09
Interest
5.30
0
5.30
Exceptional Items
-0.01
0
-0.01
Gross Profit (PBDT)
115.60
0
115.60
Depreciation
0.00
0
0.00
Profit Before Tax
42.79
0
42.79
Tax
5.50
0
5.50
Provisions and contingencies
0
0
0.00
Profit After Tax
29.09
0
29.09
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
29.09
0
29.09
Share in Profit of Associates
0
0
0.00
Minority Interest
8.19
0
8.19
Other related items
0.00
0.00
0.00
Consolidated Net Profit
37.29
0
37.29
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
987.25
0
987.25
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
26.57%
0%
0.00
26.57%
Gross Profit Margin
25.06%
0%
0.00
25.06%
PAT Margin
17.04%
0%
0.00
17.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 17.07 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -32.18% vs 51.26% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 31.11% vs 32.18% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.73 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -35.58% vs 50.39% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 26.01% vs 73.10% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.54 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -41.72% vs 39.11% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 3.89% vs 37.85% in Mar 2025

Quarterly - Interest
Interest 0.53 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 51.43% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 307.69% vs 225.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.57%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025